| Record ID | ia:presentfuturerol0024sanf |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/presentfuturerol0024sanf/presentfuturerol0024sanf_marc.xml |
| Download MARC binary | https://www.archive.org/download/presentfuturerol0024sanf/presentfuturerol0024sanf_meta.mrc |
LEADER: 04034cam 2200889 a 4500
001 ocm20852927
003 OCoLC
005 20200422004947.0
008 891218s1990 sz a b 101 0 eng
010 $a 89071669
040 $aDNLM/DLC$beng$cDLC$dNLM$dOCL$dMUQ$dBAKER$dBTCTA$dYDXCP$dOCLCG$dZWZ$dGBVCP$dOCLCO$dOCLCF$dOCLCQ$dOCLCO$dOCL$dOCLCO$dOCLCQ$dOCLCO$dCASUM$dOCLCO$dOCLCQ$dOCLCO$dOCLCA
016 7 $a900143487$2DE-101
016 7 $a9000189$2DNLM
019 $a21148361$a25868765
020 $a3805550294
020 $a9783805550291
035 $a(OCoLC)20852927$z(OCoLC)21148361$z(OCoLC)25868765
050 00 $aRC271.M65$bS26 1989
060 00 $aW3$bFR935 v.24 1990
060 10 $aQZ 266$bS195p 1989
082 00 $a616.99/40642$220
084 $a33$2sdnb
111 2 $aSan Francisco Cancer Symposium$n(24th :$d1989)
245 14 $aThe present and future role of monoclonal antibodies in the management of cancer :$b24th Annual San Francisco Cancer Symposium, San Francisco, Calif., February 10-11, 1989 /$cvolume editors, Jerome M. Vaeth, John L. Meyer.
260 $aBasel ;$aNew York :$bKarger,$c1990.
300 $avi, 265 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aFrontiers of radiation therapy and oncology ;$vvol. 24
504 $aIncludes bibliographical references and index.
650 0 $aMonoclonal antibodies$xTherapeutic use$vCongresses.
650 0 $aMonoclonal antibodies$xDiagnostic use$vCongresses.
650 0 $aCancer$xRadioimmunotherapy$vCongresses.
650 0 $aCancer$xRadioimmunoimaging$vCongresses.
650 2 $aAntibodies, Monoclonal$xtherapeutic use.
650 2 $aNeoplasms$xtherapy.
650 6 $aCancer$xImmunoscintigraphie.
650 6 $aCancer$xRadioimmunothe rapie.
650 6 $aImmunoglobulines monoclonales$xEmploi en the rapeutique$xCongre s.
650 6 $aImmunoglobulines monoclonales$xEmploi en symptomatologie$xCongre s.
650 7 $aAnticorps monoclonal.$2fmesh
650 7 $aTumeurs$xThe rapeutique.$2fmesh
650 7 $aCancer$xRadioimmunoimaging.$2fast$0(OCoLC)fst00845470
650 7 $aCancer$xRadioimmunotherapy.$2fast$0(OCoLC)fst00845471
650 7 $aMonoclonal antibodies$xDiagnostic use.$2fast$0(OCoLC)fst01025549
650 7 $aMonoclonal antibodies$xTherapeutic use.$2fast$0(OCoLC)fst01025554
650 7 $aCancer$xThe rapeutique$xCongre s.$2ram
650 7 $aAnticorps monoclonaux$xCongre s.$2ram
653 0 $aAntibodies, Monoclonal$atherapeutic use$acongresses
653 0 $aCancer$aRadioimmunoimaging$aCongresses
653 0 $aCancer$aRadioimmunotherapy$aCongresses
653 0 $aMonoclonal antibodies$aDiagnostic use$aCongresses
653 0 $aMonoclonal antibodies$aTherapeutic use$aCongresses
653 0 $aNeoplasms$atherapy$acongresses
655 2 $aCongress.
655 4 $aCongresses.
655 4 $aFulltext.
655 4 $aInternet Resources.
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
700 1 $aVaeth, Jerome M.,$d1925-
700 1 $aMeyer, John,$d1949-
776 08 $iOnline version:$aSan Francisco Cancer Symposium (24th : 1989).$tPresent and future role of monoclonal antibodies in the management of cancer.$dBasel ; New York : Karger, 1990$w(OCoLC)608771878
830 0 $aFrontiers of radiation therapy and oncology ;$vvol. 24.
856 41 $uhttps://www.karger.com/Book/Toc/221753$zAccess restricted to Stanford community
856 4 $uhttps://www.karger.com/Book/Home/221753
938 $aBaker & Taylor$bBKTY$c169.50$d169.50$i3805550294$n0001651959$sactive
938 $aBaker and Taylor$bBTCP$n89071669
938 $aYBP Library Services$bYANK$n1254650
029 1 $aAU@$b000006881992
029 1 $aGBVCP$b01821665X
029 1 $aNLGGC$b057876851
029 1 $aNLM$b9000189
029 1 $aNZ1$b3692225
029 1 $aYDXCP$b1254650
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 96 OTHER HOLDINGS